Similar companies
| Company | Transaction Value | |
|---|---|---|
 |
DentsplyXRAY |
$15M |
 |
Align TechnologyALGN |
$24M |
 |
NovoCureNVCR |
-$156M |
 |
iRhythm TechnologiesIRTC |
-$885M |
 |
LeMaitre VascularLMAT |
-$1.59B |
Are Medline Insiders Buying or Selling?
Medline (MDLN) has had 6 insider transactions in the past 90 days, all sells. The most recent was GIC Private Ltd, who sold 100,000 shares at $35.80 on August 14, 2026.
Insider trading patterns can signal confidence or concern from the people who know the company best. AltIndex tracks insider transactions as one of 25+ alternative data signals in the MDLN AI Score. For government officials trading this stock, see MDLN congressional trading.
Who’s Trading Medline Stock?
| Insider | Activity | Trades | Last Trade |
|---|---|---|---|
| STEPHEN SCHWARZMAN | Sold $2.92B | 10 | May 28, 2026 |
| HFCP X (Parallel-A), L.P. | Sold $2.65B | 12 | May 28, 2026 |
| BX Mozart ML-2 Holdco L.P. | Sold $2.35B | 8 | May 28, 2026 |
| TC Group, LLC | Sold $1.63B | 2 | Mar 10, 2026 |
| Carlyle Mozart Coinvestment Holdings, L.P. | Sold $1.63B | 2 | Mar 10, 2026 |
| TC Group Cayman Investment Holdings, L.P. | Sold $1.07B | 1 | Mar 10, 2026 |
Recent Medline Insider Transactions
| Insider | Transaction Date | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| GIC Private Ltd | Aug 14, 2026 | Sell | 100,000 | $35.8 | $3.6M |
| GIC Private Ltd | Aug 13, 2026 | Sell | 1,500,000 | $35.8 | $54M |
| GIC Private Ltd | Aug 7, 2026 | Sell | 590,284 | $35.58 | $21M |
| GIC Private Ltd | Aug 6, 2026 | Sell | 271,994 | $35.33 | $9.6M |
| GIC Private Ltd | Aug 5, 2026 | Sell | 1,710,907 | $35.46 | $61M |
| GIC Private Ltd | Aug 5, 2026 | Sell | 265,711 | $36.48 | $9.7M |
| JESSI CORCORAN | Jun 5, 2026 | Buy | 5,000 | $34.15 | $170,000 |
| HFCP X (Parallel-A), L.P. | May 28, 2026 | Sell | 17,947,337 | $36.54 | $656M |
| HFCP X (Parallel-A), L.P. | May 28, 2026 | Sell | 11,904,646 | $36.54 | $435M |
| STEPHEN SCHWARZMAN | May 28, 2026 | Sell | 19,712,326 | $36.54 | $720M |
| BX Mozart ML-2 Holdco L.P. | May 28, 2026 | Sell | 19,712,326 | $36.54 | $720M |
| HFCP X (Parallel-A), L.P. | May 28, 2026 | Sell | 1,262,726 | $36.54 | $46M |
| STEPHEN SCHWARZMAN | May 28, 2026 | Sell | 9,858,774 | $36.54 | $360M |
| STEPHEN SCHWARZMAN | May 28, 2026 | Sell | 2,256,800 | $36.54 | $82M |
| STEPHEN SCHWARZMAN | May 28, 2026 | Sell | 1,489,924 | $36.54 | $54M |
| BX Mozart ML-2 Holdco L.P. | May 28, 2026 | Sell | 9,858,774 | $36.54 | $360M |
| BX Mozart ML-2 Holdco L.P. | May 28, 2026 | Sell | 2,256,800 | $36.54 | $82M |
| BX Mozart ML-2 Holdco L.P. | May 28, 2026 | Sell | 1,489,924 | $36.54 | $54M |
| HFCP X (Parallel-A), L.P. | May 28, 2026 | Sell | 753,528 | $36.54 | $28M |
| TC Group, LLC | Mar 10, 2026 | Sell | 26,105,840 | $41 | $1.07B |
| Carlyle Mozart Coinvestment Holdings, L.P. | Mar 10, 2026 | Sell | 26,105,840 | $41 | $1.07B |
| CP Circle ML-6 Holdco, L.P. | Mar 10, 2026 | Sell | 26,105,840 | $41 | $1.07B |
| TC Group Cayman Investment Holdings, L.P. | Mar 10, 2026 | Sell | 26,105,840 | $41 | $1.07B |
| HFCP X (Parallel-A), L.P. | Mar 10, 2026 | Sell | 14,639,754 | $40.51 | $593M |
| STEPHEN SCHWARZMAN | Mar 10, 2026 | Sell | 16,479,083 | $40.51 | $668M |
| BX Mozart ML-2 Holdco L.P. | Mar 10, 2026 | Sell | 16,479,083 | $40.51 | $668M |
| HFCP X (Parallel-A), L.P. | Mar 10, 2026 | Sell | 9,801,455 | $40.51 | $397M |
| HFCP X (Parallel-A), L.P. | Mar 10, 2026 | Sell | 1,060,095 | $40.51 | $43M |
| STEPHEN SCHWARZMAN | Mar 10, 2026 | Sell | 8,241,723 | $40.51 | $334M |
| STEPHEN SCHWARZMAN | Mar 10, 2026 | Sell | 1,886,636 | $40.51 | $76M |
| STEPHEN SCHWARZMAN | Mar 10, 2026 | Sell | 1,245,544 | $40.51 | $50M |
| BX Mozart ML-2 Holdco L.P. | Mar 10, 2026 | Sell | 8,241,723 | $40.51 | $334M |
| BX Mozart ML-2 Holdco L.P. | Mar 10, 2026 | Sell | 1,886,636 | $40.51 | $76M |
| BX Mozart ML-2 Holdco L.P. | Mar 10, 2026 | Sell | 1,245,544 | $40.51 | $50M |
| HFCP X (Parallel-A), L.P. | Mar 10, 2026 | Sell | 629,933 | $40.51 | $26M |
| TC Group VII S1, L.P. | Dec 18, 2025 | Sell | 19,136,333 | $29 | $555M |
| Carlyle Mozart Coinvestment Holdings, L.P. | Dec 18, 2025 | Sell | 19,136,333 | $29 | $555M |
| TC Group, LLC | Dec 18, 2025 | Sell | 19,136,333 | $29 | $555M |
| GIC Private Ltd | Dec 18, 2025 | Buy | 12,586,206 | $29 | $365M |
| GIC Private Ltd | Dec 18, 2025 | Sell | 10,204,351 | $28.37 | $289M |
| STEPHEN SCHWARZMAN | Dec 18, 2025 | Sell | 13,462,600 | $28.37 | $382M |
| HFCP X (Parallel-A), L.P. | Dec 18, 2025 | Sell | 9,028,455 | $28.37 | $256M |
| HFCP X (Parallel-A), L.P. | Dec 18, 2025 | Sell | 5,079,306 | $28.37 | $144M |
| STEPHEN SCHWARZMAN | Dec 18, 2025 | Sell | 6,954,440 | $28.37 | $197M |
| Andrew Mills | Dec 18, 2025 | Buy | 2,586,206 | $29 | $75M |
| Charles Mills | Dec 18, 2025 | Buy | 2,441,379 | $29 | $71M |
| HFCP X (Parallel-A), L.P. | Dec 18, 2025 | Sell | 547,305 | $28.37 | $16M |
| HFCP X (Parallel-A), L.P. | Dec 18, 2025 | Sell | 461,760 | $28.37 | $13M |
| Charles Mills | Dec 18, 2025 | Buy | 137,931 | $29 | $4M |
Frequently Asked Questions: Medline Insider Trading
In the past 90 days, Medline insiders have made 0 buys and 6 sells. The net selling may indicate insiders are taking profits or reducing exposure.
The most recent sale was by GIC Private Ltd who sold 100,000 shares on August 14, 2026. View all transactions in the table on this page.
Insider buying is generally a stronger signal than insider selling, since insiders may sell for personal reasons (diversification, taxes) but typically buy only when they believe the stock is undervalued. AltIndex uses insider transaction patterns alongside 25+ other signals in the AI Score.
GIC Private Ltd has bought the most MDLN stock in the last 2 years, with a total value of $365M.
SCHWARZMAN STEPHEN A has sold the most MDLN stock in the last 2 years, with a total value of $2.92B.
The total value of insider transactions for Medline in the last 2 years is negative, amounting to -$13.8B. This suggests that insiders have predominantly sold shares, which could reflect various personal or financial considerations rather than a straightforward outlook on the company's future performance.
